NYC Gazette

Memorial Sloan Kettering Cancer Center recently released a statement about its financial results for fiscal year 2024. According to the report, the center achieved a 2.5% margin with operating revenues exceeding expenses by $202.2 million, attributed largely to clinical growth and increased patient access.

The statement noted that the operating cash flow margin remained steady at 6.6%, which is consistent with the previous year. The consistency comes despite rising costs in labor, pharmaceuticals, and medical supplies. Patient revenue saw an increase of 12.7% compared to 2023, although total operating expenses also rose by 10.0%, driven by the need to support additional patient activity.

Memorial Sloan Kettering Cancer Center emphasized its commitment to expanding patient access and managing expenses effectively to maintain financial stability.

For further financial details, the center has directed individuals to its full financial disclosure report available online.